JP2021513338A5 - - Google Patents

Info

Publication number
JP2021513338A5
JP2021513338A5 JP2020542727A JP2020542727A JP2021513338A5 JP 2021513338 A5 JP2021513338 A5 JP 2021513338A5 JP 2020542727 A JP2020542727 A JP 2020542727A JP 2020542727 A JP2020542727 A JP 2020542727A JP 2021513338 A5 JP2021513338 A5 JP 2021513338A5
Authority
JP
Japan
Prior art keywords
subject
sequence
zfn
composition
aav vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020542727A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021513338A (ja
JP7275152B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/017273 external-priority patent/WO2019157324A1/en
Publication of JP2021513338A publication Critical patent/JP2021513338A/ja
Publication of JP2021513338A5 publication Critical patent/JP2021513338A5/ja
Priority to JP2023076356A priority Critical patent/JP2023090871A/ja
Application granted granted Critical
Publication of JP7275152B2 publication Critical patent/JP7275152B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020542727A 2018-02-08 2019-02-08 操作された標的特異的なヌクレアーゼ Active JP7275152B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023076356A JP2023090871A (ja) 2018-02-08 2023-05-02 操作された標的特異的なヌクレアーゼ

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201862628016P 2018-02-08 2018-02-08
US62/628,016 2018-02-08
US201862728226P 2018-09-07 2018-09-07
US62/728,226 2018-09-07
US201862758786P 2018-11-12 2018-11-12
US62/758,786 2018-11-12
US201962795937P 2019-01-23 2019-01-23
US62/795,937 2019-01-23
US201962802092P 2019-02-06 2019-02-06
US62/802,092 2019-02-06
PCT/US2019/017273 WO2019157324A1 (en) 2018-02-08 2019-02-08 Engineered target specific nucleases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023076356A Division JP2023090871A (ja) 2018-02-08 2023-05-02 操作された標的特異的なヌクレアーゼ

Publications (3)

Publication Number Publication Date
JP2021513338A JP2021513338A (ja) 2021-05-27
JP2021513338A5 true JP2021513338A5 (cg-RX-API-DMAC7.html) 2022-02-07
JP7275152B2 JP7275152B2 (ja) 2023-05-17

Family

ID=67476462

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020542727A Active JP7275152B2 (ja) 2018-02-08 2019-02-08 操作された標的特異的なヌクレアーゼ
JP2023076356A Pending JP2023090871A (ja) 2018-02-08 2023-05-02 操作された標的特異的なヌクレアーゼ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023076356A Pending JP2023090871A (ja) 2018-02-08 2023-05-02 操作された標的特異的なヌクレアーゼ

Country Status (13)

Country Link
US (2) US11401512B2 (cg-RX-API-DMAC7.html)
EP (1) EP3749350A4 (cg-RX-API-DMAC7.html)
JP (2) JP7275152B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200118468A (cg-RX-API-DMAC7.html)
CN (1) CN111954540A (cg-RX-API-DMAC7.html)
AU (1) AU2019218118A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020015488A2 (cg-RX-API-DMAC7.html)
CA (1) CA3089587A1 (cg-RX-API-DMAC7.html)
IL (1) IL276490A (cg-RX-API-DMAC7.html)
MX (1) MX2020008272A (cg-RX-API-DMAC7.html)
RU (1) RU2020129448A (cg-RX-API-DMAC7.html)
SG (1) SG11202007440YA (cg-RX-API-DMAC7.html)
WO (1) WO2019157324A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2385251B1 (es) * 2009-05-06 2013-05-06 Fundació Privada Institut D'investigació Biomèdica De Bellvitge Adenovirus oncolíticos para el tratamiento del cáncer.
KR102712926B1 (ko) 2016-10-20 2024-10-07 상가모 테라퓨틱스, 인코포레이티드 파브리병의 치료를 위한 방법 및 조성물
US11512287B2 (en) * 2017-06-16 2022-11-29 Sangamo Therapeutics, Inc. Targeted disruption of T cell and/or HLA receptors
SG11201911729SA (en) * 2017-06-16 2020-01-30 Sangamo Therapeutics Inc Targeted disruption of t cell and/or hla receptors
CA3106691A1 (en) * 2018-08-07 2020-02-13 Sangamo Therapeutics, Inc. Method for the treatment of mucopolysaccharidosis type ii
CN113226352B (zh) 2018-08-24 2025-08-26 星火治疗有限公司 最优化启动子序列、无内含子的表达结构及使用方法
CN113423419A (zh) * 2019-01-04 2021-09-21 桑格摩生物治疗股份有限公司 用于治疗法布里病的方法和组合物
CA3106693A1 (en) 2019-02-06 2020-08-13 Sangamo Therapeutics, Inc. Method for the treatment of mucopolysaccharidosis type i
WO2021087366A1 (en) 2019-11-01 2021-05-06 Sangamo Therapeutics, Inc. Compositions and methods for genome engineering
WO2021252952A1 (en) * 2020-06-11 2021-12-16 Sangamo Therapeutics, Inc. Methods and compositions for expressing phenylalanine hydroxylase
JP7877351B2 (ja) * 2021-03-19 2026-06-22 メタゲノミ セラピューティクス,インク. Cas酵素を用いたマルチプレックス編集
CN113293165B (zh) * 2021-06-21 2022-11-15 军事科学院军事医学研究院环境医学与作业医学研究所 一种基于CRISPR-Cas12a技术的HEV特异crRNA、检测试剂盒及其应用
KR20240055084A (ko) * 2021-09-13 2024-04-26 라이프 테크놀로지스 코포레이션 유전자 편집 도구

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436150A (en) 1992-04-03 1995-07-25 The Johns Hopkins University Functional domains in flavobacterium okeanokoities (foki) restriction endonuclease
US5487994A (en) 1992-04-03 1996-01-30 The Johns Hopkins University Insertion and deletion mutants of FokI restriction endonuclease
US5356802A (en) 1992-04-03 1994-10-18 The Johns Hopkins University Functional domains in flavobacterium okeanokoites (FokI) restriction endonuclease
US6242568B1 (en) 1994-01-18 2001-06-05 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
JP4012243B2 (ja) 1994-01-18 2007-11-21 ザ スクリップス リサーチ インスティチュート 亜鉛フィンガータンパク質誘導体およびそのための方法
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
GB9824544D0 (en) 1998-11-09 1999-01-06 Medical Res Council Screening system
CA2196419C (en) 1994-08-20 2007-08-21 Yen Choo Improvements in or relating to binding proteins for recognition of dna
US5789538A (en) 1995-02-03 1998-08-04 Massachusetts Institute Of Technology Zinc finger proteins with high affinity new DNA binding specificities
US5925523A (en) 1996-08-23 1999-07-20 President & Fellows Of Harvard College Intraction trap assay, reagents and uses thereof
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
GB2338237B (en) 1997-02-18 2001-02-28 Actinova Ltd In vitro peptide or protein expression library
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
US6410248B1 (en) 1998-01-30 2002-06-25 Massachusetts Institute Of Technology General strategy for selecting high-affinity zinc finger proteins for diverse DNA target sites
DE69942334D1 (de) 1998-03-02 2010-06-17 Massachusetts Inst Technology Poly-zinkfinger-proteine mit verbesserten linkern
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US7070934B2 (en) 1999-01-12 2006-07-04 Sangamo Biosciences, Inc. Ligand-controlled regulation of endogenous gene expression
US6599692B1 (en) 1999-09-14 2003-07-29 Sangamo Bioscience, Inc. Functional genomics using zinc finger proteins
US7013219B2 (en) 1999-01-12 2006-03-14 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
US6503717B2 (en) 1999-12-06 2003-01-07 Sangamo Biosciences, Inc. Methods of using randomized libraries of zinc finger proteins for the identification of gene function
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US7030215B2 (en) 1999-03-24 2006-04-18 Sangamo Biosciences, Inc. Position dependent recognition of GNN nucleotide triplets by zinc fingers
US6794136B1 (en) 2000-11-20 2004-09-21 Sangamo Biosciences, Inc. Iterative optimization in the design of binding proteins
US6379903B1 (en) 1999-10-08 2002-04-30 Sigma-Aldrich Co. Purification of recombinant proteins fused to multiple epitopes
AU2001250774B2 (en) 2000-02-08 2005-01-27 Sangamo Biosciences, Inc. Cells expressing zinc finger proteins for drug discovery
US20020061512A1 (en) 2000-02-18 2002-05-23 Kim Jin-Soo Zinc finger domains and methods of identifying same
AU2001263155A1 (en) 2000-05-16 2001-11-26 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
US7419829B2 (en) 2000-10-06 2008-09-02 Oxford Biomedica (Uk) Limited Vector system
AU2002217929A1 (en) 2000-11-28 2002-06-11 Sangamo Biosciences, Inc. Modulation of gene expression using insulator binding proteins
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7273923B2 (en) 2001-01-22 2007-09-25 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
GB0108491D0 (en) 2001-04-04 2001-05-23 Gendaq Ltd Engineering zinc fingers
US20040224385A1 (en) 2001-08-20 2004-11-11 Barbas Carlos F Zinc finger binding domains for cnn
US7262054B2 (en) 2002-01-22 2007-08-28 Sangamo Biosciences, Inc. Zinc finger proteins for DNA binding and gene regulation in plants
ATE347593T1 (de) 2002-01-23 2006-12-15 Univ Utah Res Found Zielgerichtete chromosomale mutagenese mit zinkfingernukleasen
EP1504092B2 (en) 2002-03-21 2014-06-25 Sangamo BioSciences, Inc. Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
US7361635B2 (en) 2002-08-29 2008-04-22 Sangamo Biosciences, Inc. Simultaneous modulation of multiple genes
US9447434B2 (en) 2002-09-05 2016-09-20 California Institute Of Technology Use of chimeric nucleases to stimulate gene targeting
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US8409861B2 (en) 2003-08-08 2013-04-02 Sangamo Biosciences, Inc. Targeted deletion of cellular DNA sequences
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
ATE418346T1 (de) 2004-04-08 2009-01-15 Sangamo Biosciences Inc Zusammensetzungen zur behandlung von neuropathischen und neurodegenerativen erkrankungen
US7253273B2 (en) 2004-04-08 2007-08-07 Sangamo Biosciences, Inc. Treatment of neuropathic pain with zinc finger proteins
KR20070060115A (ko) 2004-09-16 2007-06-12 상가모 바이오사이언스 인코포레이티드 단백질 생산을 위한 조성물 및 방법
EP1913149A4 (en) 2005-07-26 2009-08-05 Sangamo Biosciences Inc TARGETED INTEGRATION AND EXPRESSION OF EXOGENOUS NUCLEIC ACID SEQUENCES
US7951925B2 (en) 2006-05-25 2011-05-31 Sangamo Biosciences, Inc. Methods and compositions for gene inactivation
EP2027262B1 (en) 2006-05-25 2010-03-31 Sangamo Biosciences Inc. Variant foki cleavage half-domains
US8110379B2 (en) 2007-04-26 2012-02-07 Sangamo Biosciences, Inc. Targeted integration into the PPP1R12C locus
US8563314B2 (en) 2007-09-27 2013-10-22 Sangamo Biosciences, Inc. Methods and compositions for modulating PD1
CA2720903C (en) 2008-04-14 2019-01-15 Sangamo Biosciences, Inc. Linear donor constructs for targeted integration
JP5763530B2 (ja) 2008-06-10 2015-08-12 サンガモ バイオサイエンシーズ, インコーポレイテッド Bax−およびBak−欠損細胞株の生成のための方法および組成物
JP5908725B2 (ja) 2008-08-22 2016-04-26 サンガモ バイオサイエンシーズ, インコーポレイテッド 標的一本鎖開裂および標的組込みのための方法、並びに組成物
EP3156494B8 (en) 2008-12-04 2018-09-19 Sangamo Therapeutics, Inc. Genome editing in rats using zinc-finger nucleases
EP2206723A1 (en) 2009-01-12 2010-07-14 Bonas, Ulla Modular DNA-binding domains
US8956828B2 (en) 2009-11-10 2015-02-17 Sangamo Biosciences, Inc. Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
JP6137596B2 (ja) * 2010-02-08 2017-05-31 サンガモ セラピューティクス, インコーポレイテッド 遺伝子操作された切断ハーフドメイン
US9255259B2 (en) 2010-02-09 2016-02-09 Sangamo Biosciences, Inc. Targeted genomic modification with partially single-stranded donor molecules
US9567573B2 (en) 2010-04-26 2017-02-14 Sangamo Biosciences, Inc. Genome editing of a Rosa locus using nucleases
EP2566972B1 (en) 2010-05-03 2020-01-15 Sangamo Therapeutics, Inc. Compositions for linking zinc finger modules
AU2011256838B2 (en) 2010-05-17 2014-10-09 Sangamo Therapeutics, Inc. Novel DNA-binding proteins and uses thereof
CA2805442C (en) 2010-07-21 2020-05-12 Sangamo Biosciences, Inc. Methods and compositions for modification of an hla locus
CN102358902B (zh) * 2011-04-02 2013-01-02 西南大学 家蚕丝素重链基因突变序列及突变的方法和应用
EP2758529B1 (en) 2011-09-21 2019-03-20 Sangamo Therapeutics, Inc. Methods and compositions for regulation of transgene expression
US9222105B2 (en) 2011-10-27 2015-12-29 Sangamo Biosciences, Inc. Methods and compositions for modification of the HPRT locus
WO2013074999A1 (en) 2011-11-16 2013-05-23 Sangamo Biosciences, Inc. Modified dna-binding proteins and uses thereof
HUE051612T2 (hu) 2012-07-11 2021-03-01 Sangamo Therapeutics Inc Eljárások és készítmények lizoszomális tárolási betegségek kezelésére
EP2890780B8 (en) * 2012-08-29 2020-08-19 Sangamo Therapeutics, Inc. Methods and compositions for treatment of a genetic condition
CA2892448A1 (en) 2012-12-05 2014-06-12 Sangamo Biosciences, Inc. Methods and compositions for regulation of metabolic disorders
EP2935319B1 (en) 2012-12-18 2019-04-24 Novartis AG Production of therapeutic proteins in genetically modified mammalian cells
EP2997146A4 (en) 2013-05-15 2017-04-26 Sangamo BioSciences, Inc. Methods and compositions for treatment of a genetic condition
CA2920899C (en) 2013-08-28 2023-02-28 Sangamo Biosciences, Inc. Compositions for linking dna-binding domains and cleavage domains
CA3229275A1 (en) * 2013-12-09 2015-06-18 Sangamo Biosciences, Inc. Methods and compositions for genome engineering
US10179918B2 (en) 2015-05-07 2019-01-15 Sangamo Therapeutics, Inc. Methods and compositions for increasing transgene activity
US10143760B2 (en) 2015-10-28 2018-12-04 Sangamo Therapeutics, Inc. Liver-specific constructs, factor VIII expression cassettes and methods of use thereof
AU2016374253B2 (en) 2015-12-18 2021-10-21 Sangamo Therapeutics, Inc. Targeted disruption of the MHC cell receptor
EP3402533B1 (en) * 2016-01-15 2021-08-04 Sangamo Therapeutics, Inc. Methods and compositions for the treatment of neurologic disease
WO2018039440A1 (en) 2016-08-24 2018-03-01 Sangamo Therapeutics, Inc. Regulation of gene expression using engineered nucleases
IL264792B2 (en) 2016-08-24 2023-10-01 Sangamo Therapeutics Inc Engineered target-specific zinc-finger nucleases
US20180185516A1 (en) 2016-12-09 2018-07-05 Sangamo Therapeutics, Inc. Delivery of target specific nucleases
CA3106691A1 (en) * 2018-08-07 2020-02-13 Sangamo Therapeutics, Inc. Method for the treatment of mucopolysaccharidosis type ii

Similar Documents

Publication Publication Date Title
RU2020129448A (ru) Сконструированные специфические для мишени нуклеазы
JP2017500061A5 (cg-RX-API-DMAC7.html)
JP2020500162A5 (cg-RX-API-DMAC7.html)
JP2017504354A5 (cg-RX-API-DMAC7.html)
Almeida-Porada et al. Therapeutic mesenchymal stromal cells for immunotherapy and for gene and drug delivery
Hadebe et al. The SAFE pathway for cardioprotection: is this a promising target?
Matsunari et al. Compensation of disabled organogeneses in genetically modified pig fetuses by blastocyst complementation
Wang et al. Gliptins suppress inflammatory macrophage activation to mitigate inflammation, fibrosis, oxidative stress, and vascular dysfunction in models of nonalcoholic steatohepatitis and liver fibrosis
Tipanee et al. Transposons: moving forward from preclinical studies to clinical trials
Bösl et al. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp)
Paradies et al. Cardiolipin and mitochondrial function in health and disease
Thrasher et al. Evolving gene therapy in primary immunodeficiency
Torii et al. Molecular cloning and functional analysis of apoxin I, a snake venom-derived apoptosis-inducing factor with L-amino acid oxidase activity
Myers et al. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
Amelio et al. p63 the guardian of human reproduction
JP2016539627A5 (cg-RX-API-DMAC7.html)
Carvalho et al. Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction
JP2018531614A5 (cg-RX-API-DMAC7.html)
JP2015533786A5 (cg-RX-API-DMAC7.html)
Benoit et al. A novel highly divergent protein family identified from a viviparous insect by RNA-seq analysis: a potential target for tsetse fly-specific abortifacients
JP2020505044A5 (cg-RX-API-DMAC7.html)
Samarelli et al. Dissecting the role of mesenchymal stem cells in idiopathic pulmonary fibrosis: cause or solution
Mo et al. Evidence that DNA polymerase δ isolated by immunoaffinity chromatography exhibits high-molecular weight characteristics and is associated with the KIAA0039 protein and RPA
Tompa et al. The calpain cascade: μ-calpain activates m-calpain
JP2020524994A5 (cg-RX-API-DMAC7.html)